Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Billionaire Louis Bacon’s Moves Reveal Less Trust for Top Tech Names

Page 1 of 2

Billionaire Louis Bacon steered his fund Moore Capital Management through treacherous waters in the first half of 2015 and delivered reasonable gains, with his firm’s Global Investment Fund up by 4.8% and the Macro Management Fund posting 3.61% gains (both net of fees). The investment manager has a knack for disengaging from possibly problematic investments before they embark on a steep downhill trajectory. For instance, the fund slashed its holding in Alibaba Group Holding Ltd (NYSE:BABA) by 90% during the fourth quarter of last year. The stock has plunged by about 22% so far this year. This warrants an inspection of Bacon’s top stock picks heading into the fourth quarter, some of which he has also begun to make cuts to.

At Insider Monkey we don’t just track the latest moves of hedge funds. We are, in fact, more interested in their 13F filings, which we use to determine the top 15 small-cap stocks held by the funds we track. We gather and share this information based on 16 years of research which showed that these 15 most popular small-cap picks have a great potential to outperform the market, beating the S&P 500 Total Return Index by nearly one percentage point per month in backtests, and easily beating the most popular large-cap picks of funds, which nonetheless get the majority of their collective capital. Why pay fees to invest in both the best and worst ideas of a particular hedge fund when you can simply mimic only the very best ideas of the best fund managers on your own? Since the beginning of forward testing in August 2012, the Insider Monkey small-cap strategy has outperformed the market every year, returning 102%, more than two-times greater returns than the S&P 500 during the same period (see the details here).

Louis Bacon
Louis Bacon
Moore Global Investments

#5 Taubman Centers, Inc. (NYSE:TCO)

Shares held (as of September 30): 375,000

Total Value (as of September 30): $25.91 million

Moore boosted its stake in the $4.40 billion REIT by 25% during the September trimester. The mall operator’s stock price has fallen by about 4.5% since the start of the year and Evercore downgraded the stock to ‘Hold’ from ‘Buy’ last month, citing retail weakness across a variety of subsectors. Regardless, John Khoury’s Long Pond Capital is also bullish on Taubman Centers, Inc. (NYSE:TCO), having upped its stake by 42% to 3.76 million shares during the last quarter.

#4 Facebook Inc (NASDAQ:FB)

Shares held (as of September 30): 375,000

Total Value (as of September 30): $33.71 million

During the July-to-September period, Moore slashed its holding in the owner of the world’s largest social media platform by 56%. The move might have been ill-conceived in this case, considering that Facebook Inc (NASDAQ:FB)’s stock price has surged by almost 16% since the end of September, and is up by more than 35% this year. The company managed to beat both the top and bottom line estimates in its financial results for the third quarter. However, the investment manager could be thinking about a possible rate hike by the Fed in the near future, which could take a toll on growth stocks like Facebook. Among the more than 700 hedge funds that we track, Lone Pine Capital, led by Stephen Mandel, is the largest stockholder of Facebook Inc (NASDAQ:FB), holding more than 10.7 million shares.

Follow Facebook Inc (NASDAQ:FB)
Trade (NASDAQ:FB) Now!
Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!